NCT02141477 2018-02-13
Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)
M.D. Anderson Cancer Center
Phase 1 Terminated
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Teva Branded Pharmaceutical Products R&D, Inc.